Envisioning a world where
all can see a brighter future.
KeraLink International (KLI) works to prevent, detect and treat corneal disease and blindness by providing innovative and affordable solutions and technologies to underserved populations in lower-and middle-income communities. KLI unites clinicians, technology innovators, social entrepreneurs, and donors in a coordinated and collaborative effort to address this treatable disease. Ultimately, we envision a world where all can see a brighter future.
People worldwide are living with corneal blindness
Of people with corneal blindness live in low- and middle-income countries (LMICs)
Of people who need a cornea transplant in low- and middle-income countries (LMICs) will not get one
Corneal blindness is preventable, treatable, and reversible.
No one needs to be blind due to corneal disease or injury.
However, treatment and care for corneal diseases and injuries are often inaccessible or unaffordable in low- and middle-income countries (LMICs).
CAUSES & CONSEQUENCES
Corneal blindness can be caused by infection, injury, inflammation, or inherited conditions. It primarily impacts young people in LMICs and has profound social and economic consequences, including:
Reduced Quality of Life
Educational Barriers
Loss of Productivity
Gender Disparities
Increased Healthcare Costs
THE PEN STRATEGY
We use a collaborative three-pronged approach for holistic cornea care.
PREVENTION
We work to prevent injuries and infections that can lead to corneal blindness.
Conditions Targeted for Prevention:
Injury
Infection
Our Prevention Initiatives:
- Protective Eyewear
EARLY DETECTION & RAPID TREATMENT
Conditions Targeted in Early Detection:
Keratoconus
Keratitis
Our Early Detection Initiatives:
- Diagnostic Devices & AI Algorithms
- Non-Pharmaceutical Antimicrobial
NOVEL TREATMENTS & TECHNOLOGY
Preserving & restoring sight using affordable & sustainable novel treatments
Treatments Being Developed:
